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Abstract
Background: In 2006, a novel gammaretrovirus, XMRV (xenotropic murine leukemia virus-related virus), was
discovered in some prostate tumors. A more recent study indicated that this infectious retrovirus can be detected
in 67% of patients suffering from chronic fatigue syndrome (CFS), but only very few healthy controls (4%).
However, several groups have published to date that they could not identify XMRV RNA or DNA sequences in
other cohorts of CFS patients, while another group detected murine leukemia virus (MLV)-like sequences in 87% of
such patients, but only 7% of healthy controls. Since there is a high degree of similarity between XMRV and
abundant endogenous MLV proviruses, it is important to distinguish contaminating mouse sequences from true
infections.
Results: DNA from the peripheral blood of 112 CFS patients and 36 healthy controls was tested for XMRV with
two different PCR assays. A TaqMan qPCR assay specific for XMRV pol sequences was able to detect viral DNA from
2 XMRV-infected cells (~ 10-12 pg DNA) in up to 5 μg of human genomic DNA, but yielded negative results in the
test of 600 ng genomic DNA from 100,000 peripheral blood cells of all samples tested. However, positive results
were obtained with some of these samples, using a less specific nested PCR assay for a different XMRV sequence.
DNA sequencing of the PCR products revealed a wide variety of virus-related sequences, some identical to those
found in prostate cancer and CFS patients, others more closely related to known endogenous MLVs. However, all
samples that tested positive for XMRV and/or MLV DNA were also positive for the highly abundant intracisternal
A-type particle (IAP) long terminal repeat and most were positive for murine mitochondrial cytochrome oxidase
sequences. No contamination was observed in any of the negative control samples, containing those with no DNA
template, which were included in each assay.
Conclusions: Mouse cells contain upwards of 100 copies each of endogenous MLV DNA. Even much less than one
cell’s worth of DNA can yield a detectable product using highly sensitive PCR technology. It is, therefore, vital that
contamination by mouse DNA be monitored with adequately sensitive assays in all samples tested.
Background
XMRV (xenotropic murine leukemia virus-related virus)
is a novel gammaretrovirus that was identified in 2006
in 10% of prostate cancers [1]. Its functional significance
was implied by the recent observation that it is preva-
lent mainly in more aggressive tumors [2]. In 2009, it
w a sr e p o r t e dt h a t6 7 %o fc h r o n i cf a t i g u es y n d r o m e
(CFS) patients had this infectious gammaretrovirus,
while only a small fraction of healthy volunteers was
XMRV-positive [3]. These data were received with
enthusiasm because they pointed to a possible infectious
etiology of CFS, a chronic disability that is clinically ill-
defined. However, several research groups challenged
these conclusions almost immediately [4-11] because
they could not detect the predicted PCR products or
antibodies in cohorts of CFS or prostate cancer patients
(reviewed in [12-15]).
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viruses (MLVs) were reported in 80% of CFS patients ver-
sus only a small percentage of healthy controls [16]. This
finding implicated different retroviruses specifically linked
to this patient population than the originally described
XMRV [3]. The similarity of such sequences to large num-
bers of endogenous MLVs present in any mouse strain
[17-19] complicates interpretation of detection of such
sequences in clinical studies since possible contamination
of the human samples with mouse DNA [14,20] has to be
rigorously ruled out to validate such results.
Our laboratory has been involved in CFS research
since 2005 and has a substantial library of samples
stored from a cohort of patients and controls. Using a
nested PCR for XMRV, we detected one XMRV-like
and various MLV-like sequences, but also observed a
100% correlation between samples that were positive for
XMRV/MLV sequences and those positive for mouse
DNA, while most samples negative for XMRV/MLV
were also negative for mouse DNA. These results imply
frequent laboratory contamination with minute and
highly variable quantities of mouse DNA.
Results
Study populations
We analyzed a library of 111 stored DNA samples that
had been collected from the peripheral blood mononuc-
lear cells (PBMC) of CFS patients in 2005 for an unre-
lated project (see Methods section for description). In
addition, we collected 37 blood samples (one CFS and
36 healthy controls) in 2009-2010.
TaqMan qPCR specific for XMRV did not reveal positive
individuals
The original XMRV results from patients with prostate
cancer and CFS were obtained using a sensitive nested
PCR assay for XMRV [1,3] that also detects endogenous
MLV sequences in murine genomic DNA. These data
were later extended, employing a qPCR assay specific
for a region in the XMRV pol gene not cross-reactive
with any sequence known to be present in mouse DNA
[2, Singh, personal communication]. To test our cohort
for the presence of XMRV sequences, we analyzed
PBMC DNA with this 2
nd qPCR assay, using the pri-
mers and probe as described in [2]. Titration of DNA
from an XMRV-positive lymphoblastoid cell line, WPI-
1282 (kindly provided by the Whittemore Peterson
Institute (WPI)), resulted in detection of XMRV down
to 10-12 pg, equivalent to two cells, in the presence or
absence of 5 μg control DNA isolated from the human
LnCaP cell line (Figure 1). However, no positive
response (Ct > 60) was obtained with DNA from 112
CFS patients and 36 healthy controls, when tested at
600 ng to 5 μg per reaction (data not shown). These
data indicated that our samples were either XMRV-
negative or had more divergent MLV sequences than
originally described [1,3]. In the latter case, the qPCR
assay used, which is sensitive to small sequence differ-
ences, would not have allowed detection.
Nested PCR for XMRV gag yielded a high frequency of
positive samples
To explore the possibility that XMRV sequences in
humans are more divergent than previously reported,
we used the nested PCR assay for XMRV gag sequences
mentioned above, which also detects many endogenous
MLV proviruses, as described [1]. A preliminary titra-
tion experiment revealed that MLV-like sequences could
b ed e t e c t e di n2 - 3p go fW P I - 1 2 8 2D N A ,e q u i v a l e n tt o
<1 cell, when mixed with 200 ng control DNA (see
above) (Figure 2). This assay was used to test DNA in
triplicates of 200 ng each from our CFS and control
cohorts. Surprisingly, a high proportion of DNA samples
from the healthy volunteers (19/36), but only 2/112 of
the CFS patients, yielded PCR products of the correct
s i z e ,a st e s t e do na na g a r o s eg e l .N o n eo ft h e“no tem-
plate” control samples, included in each assay at least in
triplicate, gave positive results. These data suggested
that XMRV-related viruses may be highly prevalent in
the human population, but no special link of these
viruses to CFS patients was indicated. While all the
blood samples were processed in the Huber laboratory,
it should be noted that the CFS cohort mainly consisted
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Figure 1 Sensitivity of TaqMan qPCR for IN region in XMRV
pol. Titration of DNA from WPI-1282 (1.7, 16.7, and 166.7 cell
equivalents) in the absence (square, solid line, slope = -3.14) or in
the presence of 8.3 × 10
5 cell equivalents of genomic LNCaP DNA
(circle, dotted line, slope = -3.04). 1.7 cell equivalents of WPI-1282
genomic DNA is detectable in 8.3 × 10
5 cell equivalents of
background DNA. Samples were run in duplicates. All qPCR
reactions were run for 60 cycles. Samples that did not produce a
signal after 60 cycles were assumed negative for XMRV. Ct = Cycle
Threshold
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whereas the healthy volunteers were recruited more
recently, between November of 2009 and May of 2010,
and, as discussed later, were processed using a slightly
different protocol.
Sequence analysis of the gag PCR products revealed high
polymorphism
To determine the relationship among the various PCR
products, we obtained their DNA sequences. We observed
that most amplicons contained mixtures of sequences,
thus, necessitating limiting dilutions of the original DNA
samples to obtain pure sequences for analysis (Figures 2B
&3, Additional File 1; Table S1). A total of 37 clean
sequences of single PCR products (designated TH for
“Tufts Huber”) were obtained in this way from 21 samples
(19 healthy controls and 2 CFS). Surprisingly, a high
degree of diversity was seen in these viral sequences
(Figure 3 Additional File 1; Table S1), revealing both
XMRV-like and endogenous MLV sequences and implying
15 different virus strains. While 3 healthy controls had
sequences that were identical to the corresponding seg-
ment of XMRV strain VP42, a viral isolate that was origin-
ally found in prostate cancer [1] and later in CFS patients
[3], the remaining samples were either identical or closely
related to known endogenous MLVs [17-19].
The sequences obtained were also analyzed by con-
structing neighbor-joining trees (Figure 4). Again, our
data indicate a high degree of polymorphism in the
MLV-like sequences found. In contrast to the published
VP [1] and WPI [3] XMRV sequences, which are tightly
clustered, the gag sequences found in this study were
dispersed, similar to the sequences reported in [16]; i.e.,
the 15 unique XMRV-related partial gag sequences
found among from the 37 single PCR products were dis-
tributed over a minimum of 3 clusters, each of which
contains endogenous MLV sequences of a different sub-
type (XMV, PMV, and MPMV (xenotropic, polytropic,
modified polytropic MLV)).
Tests for mouse DNA contamination revealed correlation
with viral sequences
Endogenous MLVs are present in high copy number in
all inbred and many species of wild mice, making mouse
DNA a possible source of the sequences observed. To
test whether contamination with mouse DNA might
account for the observed results, all human DNA sam-
ples were screened using two different assay systems, a
TaqMan qPCR assay for murine mitochondrial cyto-
chrome oxidase, cox2 (W. Switzer, personal communica-
t i o n )a n das i n g l eP C Ra s s a yf o rt h eh i g h l ya b u n d a n t
intracisternal A-type particle (IAP) long terminal repeat
sequences, developed by us (OC and JMC, in prepara-
tion) (see DNA sequences of some IAP amplicons in
Additional File 2; Figure S1). Both assays had similar
sensitivity, detecting the target sequences in 0.6 pg of
mouse DNA, equivalent to 1/10 of a cell in a back-
ground of 200 ng LnCap DNA (Figure 5A &5B). Using
these two test systems, we observed that many samples,
both CFS and control, were positive for these types of
sequence, while all “no template” controls were negative.
A direct comparison of the gag PCR results with those
obtained in the two assays for mouse DNA revealed a
100% correlation between samples positive for the for-
mer and mouse DNA; all human DNA samples that
were positive in the gag PCR assay were also positive for
IAP sequences, and all but 2 were positive for mouse
cox2 sequences (Table 1). In addition, nearly half (62/
127) of the samples were positive for mouse DNA by
either IAP or both assays, but did not yield a detectable
MLV signal. These findings are in agreement with our
observation that the two PCR assays for mouse DNA
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Figure 2 Sensitivity of nested PCR for XMRV gag. A) Titration of
genomic DNA from WPI-1282. PCR amplicons from 83.3, 13.8, 2.3,
0.3, 0.05 and 0 cell equivalents of genomic DNA from the WPI-1282
cell line in the presence of 3.3 × 10
4 cell equivalents of LNCaP
genomic DNA were run on a 1.5% agarose gel to show the
sensitivity of the assay. gapdh was used as the loading control.
XMRV gag yields an expected product of 413 bp. NTC = No
Template Control. B) Representative example of nested PCR for
XMRV gag. Sample TH03.1.1 was first tested at 3.3 × 10
4 cell
equivalents of genomic DNA, followed by limiting dilutions of 1.1 ×
10
4 and 3.7 × 10
3 cell equivalents. Once a dilution had 1 out of 3
samples positive for gag, the positive band was purified and
sequenced.
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PCR assay, when tested on genomic mouse DNA, and
that the IAP assay is more sensitive than the cox2 assay
for detection of mouse DNA. Overall, our data are con-
sistent with the conclusion that the positive results
obtained with the XMRV gag PCR assay are due to vari-
able contamination of the human samples with mouse
DNA, most likely in laboratory reagents.
Discussion
In 2005, we initiated a study to examine the expression
level of an endogenous human betaretrovirus, HERV-
K18, in chronically ill CFS patients versus healthy con-
trols. For this purpose, we accumulated a library of
DNA samples from CFS patients which has allowed us
to investigate the possible association of XMRV with
this disease [3]. We initiated our studies on XMRV
using a TaqMan qPCR assay for a region in XMRV pol
that is unique to XMRV and does not detect any
sequences in genomic DNA from laboratory strains of
inbred mice [2]. None of the samples from either CFS
patients or healthy controls was positive in this assay,
although we were able to detect a signal from two
XMRV-infected lymphoblastoid cells (cell line WPI-
Figure 3 Gag sequences from patient samples. Individual 382 bp sequences, free of double peaks and confirmed through forward and
reverse sequencing, are compared in a Highlighter plot to the control WPI-1282 cell line sequence, VP62. The samples were coded to remain
anonymous, with the first number being the patient number, the second number being the bleed number, the third number being the tube of
DNA, and the letter showing that we have multiple sequences in the same tube of DNA. Identical sequences were collapsed into individual
clusters, those with more than two sequences are labeled TH+(N), where N is the total number of sequences in that cluster. CFS Type 1, 2 & 3
are from Lo et al. [15]. Each vertical line shows a single nucleotide difference between the labeled sequence and the control VP62 sequence.
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6 human
LnCaP cells. In our hands, the qPCR assay is 10-fold
less sensitive than the nested XMRV gag PCR assay
when tested on the same XMRV-positive cell line, since
the latter can detect a signal in DNA from <1 cell. This
difference is a consideration for the negative results we
obtained as the sensitivity of the qPCR assay may not
have been adequate for the detection of minute amounts
of XMRV. We are not aware of any other group who
has used this technique for the detection of XMRV in
the DNA of freshly isolated PBMC. However, Danielson
et al. recently reported that they could only detect
XMRV sequences, using XMRV env,b u tn o tgag,p r i -
mers [21].
In contrast to the qPCR results, we were able to read-
ily detect XMRV using the nested PCR originally
described by Urisman et al. [1], and we found many
more positive samples in our healthy control cohort,
compared to the CFS cohort. Of possible relevance for
the interpretation of these findings may be the fact that
the samples from the two cohorts were prepared years
apart, although all in the same laboratory using some-
what different protocols and reagents. It is also impor-
tant to point out that individual DNA samples remained
reproducibly positive or negative on repeat examination
rendering the possibility of random contamination of
the PCR assays very unlikely. Furthermore, each assay
contained positive and negative controls which were
100% correlative; i.e., the DNA from the XMRV-infected
cell line was always positive and the no-template control
or LnCaP DNA was always negative. Thus, it is unlikely
that contamination occurred at the time of setting up
the PCR reactions.
To further understand the origin of the positive PCR
signals, we determined the DNA sequences of the gag
PCR products. In most cases, it was only possible to
obtain unique sequences from PCR products after dilu-
tion of the input DNA to an extent where single mole-
cules were amplified, since initial studies showed that
most of the positive samples contained mixtures of clo-
sely related sequences. In this way, we obtained 15 dif-
ferent sequences from a total of 37 single PCR products.
When compared to the collection of endogenous MLV
sequences extracted from the sequenced mouse genome
[18,22], these sequences included examples from all
parts (XMV, PMV, and MPMV) of the resulting neigh-
bor-joining tree, as well as a cluster of three sequences
identical (in this region) to the VP42 isolate of XMRV.
With regard to the latter result, it is of significance that
no VP42 plasmid, nor VP42-containing cell line, nor
isolated DNA, was present in the Huber laboratory that
could have resulted in contamination (WPI-1282 con-
tains VP62 which differs by one base change in the
region analyzed). The genomic DNA from the three
Figure 4 Neighbor Joining Tree of gag fragments. A neighbor-
joining tree was constructed using the 382 bp gag fragments
detected from the PBMC DNA of 17 healthy controls and 2 CFS
patients, along with various endogenous and exogenous MLV
sequences. Identical sequences were collapsed into individual
clusters, where a representative member is shown followed by
“+(N)”, where N is the total number of sequences in that cluster.
Distances were calculated based on the absolute number of base
substitutions; all sites containing gaps were ignored. Note the
extensive variation of sequences detected in our samples (TH,
shown in red), which cluster with known Xmv (purple), Pmv (blue),
Mpmv (green) and XMRV (yellow) sequences.
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Figure 5 Tests for mouse DNA. A) TaqMan qPCR for murine mitochondrial cytochrome oxidase (mcox2). Titration of DNA from the murine EL4
cell line (100, 10, 1, 0.1, and 0.01 cell equivalents) in the absence (triangle, solid line, slope = -3.58) or in the presence of 3.3 × 10
4 cell
equivalents of background genomic LNCaP DNA (square, dotted line, slope = -2.58). 0.1 cell equivalents of murine DNA were observed in 3.3 ×
10
4 cell equivalents of background DNA. Samples were run in duplicate. All qPCR reactions were run for 60 cycles. Samples that did not produce
a signal after 60 cycles were considered negative for murine DNA. B) IAP PCR. Titration of DNA from the murine EL4 cell line (10, 1, and 0.1 and
0 cell equivalents) in the presence of 3.3 × 10
4 cell equivalents of genomic LNCaP DNA. The limit of detection was 0.1 cell equivalents of murine
DNA in 3.3 × 10
4 cell equivalents of background DNA. Although not visible here, bands of different sizes and unrelated sequence are sometimes
visible in samples analyzed with human DNA alone. NTC = No Template Control.
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contained other MLV sequences. Thus, it is not possible
for us to distinguish which one of the retroviruses
stemmed from mouse DNA contamination; i.e.,i ti sf o r -
mally possible that VP42 is an actual human retrovirus.
It is also possible that it is an endogenous provirus, not
present in the sequenced C57Bl/6 genome, but present
in the mouse species responsible for the sequences
observed [19]. In the former case, the presence of VP42
in DNA from healthy control samples, but not CFS
patients, would indicate that this virus is spread ran-
domly through the human population, with no particu-
lar link to CFS. Further analyses are required to clarify
this issue.
The presence of mixtures of MLV sequences, all clo-
sely related to known endogenous MLVs [17-19], in
many of the DNA samples tested is not easily reconciled
with infection of human hosts with the corresponding
viruses (reviewed in [14,20]). Two assays specific for
murine DNA, for mitochondrial cox2 and IAP
sequences, were used to test the possibility that there
might be trace amounts of mouse DNA contaminating
some of the samples. Consistent with this idea, we
found that each DNA sample that was positive for
XMRV/MLV also was positive for mouse DNA by the
IAP assay, while >50% of XMRV/MLV-negative samples
were positive for mouse DNA which is particularly strik-
ing in the CFS group. Again, these results were con-
firmed in repeat experiments and never deviated in
subsequent analyses, suggesting that contamination hap-
pened either during collection of blood, isolation of
PBMC, or during the preparation of the DNA from the
PBMC. We interpret these data that possible contamina-
tion with mouse DNA is ubiquitous, but the level
seemed to vary significantly from batch to batch of sam-
ple preps, although all experimental procedures were
carried out in the same facility. In particular, although
samples collected at both times showed signs of con-
tamination, the level of contamination in the normal
controls collected in 2009-2010 was noticeably greater
than in the CFS samples from 2005. To date, we have
not been able to pinpoint a specific reagent or labora-
tory vessel for being consistently positive for mouse
DNA, but preliminary experiments implicate both fetal
calf serum (FCS) and phosphate buffered saline (PBS),
although large variations in the surmised amount of
contaminating mouse DNA were observed from bottle
to bottle. All blood samples were collected in heparin
tubes rendering the anti-coagulant also a likely suspect
for mouse DNA contamination. However, a comparison
of parallel blood collections from the same healthy indi-
vidual in heparin, Na-citrate and EDTA tubes did not
support this hypothesis. In this particular set of samples
only one DNA aliquot from Na-citrate-collected blood
was positive for mouse DNA (results not shown).
Currently there are highly discordant reports in the lit-
erature about the prevalence of XMRV in CFS and pros-
tate cancer patients (reviewed in [12-15]). The original
publication on CFS patients reported that almost 70% of
these patients, but less than 5% of healthy individuals,
harbor this virus [3], and that infectious virus and anti-
viral antibodies could be detected in blood from these
patients. Several reports have appeared in the literature
since then contesting these findings [4-6,8,9], while a
recent publication claimed that 80% of CFS patients, but
not healthy controls, contained endogenous MLV-like
sequences, but were negative for mouse mitochondrial
DNA [16]. The sequences from CFS patients identified in
this latter paper were distinct from the XMRV of the ori-
ginal reports. A plausible explanation for these discrepant
results has not been put forward to date [13,14], but it is
worth pointing out that the sequences identified in the
latter report were similar to the ones we found in the
present study. Endogenous MLVs are abundant in all
laboratory mouse strains [17,18], as well as in wild Mus
species [19] and are carried by some human cell lines
that have been propagated in vivo in nude mice [20].
Thus, extreme precautions have to be taken to exclude
Table 1 Correlation of MLV DNA sequence detection with mouse DNA contamination
CFS Patients Healthy Controls**
XMRV GAG cox IAP # of Samples (n = 112) Percent # of Samples (n = 36) Percent
++ + 2* 1.8 17 47.2
-- - 53 47.3 12 33.3
+- - 0 000
+- + 0 0 2 5.6
++ - 0 000
-+ + 10 9.0 1 2.8
-- + 47 42.0 4 11.1
-+ - 0 000
*One CFS sample from 2005 collection, and one CFS sample from 2010 collection. All the other CFS samples were collected in 2005.
**All collected in 2009-2010.
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dant MLV-producing cell line.
Conclusions
In our study we have observed that 100% of human DNA
samples prepared in our laboratory that were positive for
XMRV/MLV sequences were also positive for minute
quantities of mouse DNA. Together with the similarity of
the MLV sequences to multiple identified endogenous
MLVs [17-19], this result provides a strong suspicion that
the viral sequences detected in these samples were actually
of murine origin. It is important to point out that negative
controls included in each assay never yielded positive
results, either for XMRV/MLV, or for mouse DNA,
excluding the possibility that contamination with mouse
DNA occurred at the bench during the final PCR assay,
even though mouse derived cells and tissues are regularly
used in our laboratory. Of particular interest is the wide
variety of sequences that we obtained, spanning both
XMRV and various MLV sequences. While most of the
MLV-related sequences were identical to gag segments in
nonecotropic MLVs from inbred mice [17,18], some were
found to be unique; i.e., they have so far not been identi-
fied in the sequenced mouse genome [22], but may be pre-
sent in other laboratory strains or wild mice. Thus, our
data are compatible with the conclusion that the detection
of MLV-related sequences in human genomic DNA sam-
ples could be due to contamination with minute and vari-
able quantities of mouse DNA, most likely contained in
various laboratory reagents.
Methods
Sample collection
All samples were collected according to the institutional
guidelines of Tufts University, after receiving informed
consent. The 36 healthy individuals (15 females and 21
males) were recruited on a voluntary basis by the Huber
laboratory and were between 18 and 65 years of age. The
112 CFS patients (89 females, 20 males and 3 unknown),
recruited by Dr. Susan Levine, were between 18 and 65
years of age and resided in the Northeastern United
States. All patients were diagnosed for CFS according to
CDC criteria [23], and the majority was completely dis-
abled. The cohort comprised a combination of those with
an abrupt and others with a gradual onset of symptoms.
Preparation of human blood samples
Approximately 30 ml of blood were drawn into three
heparinized tubes (Becton Dickinson) and shipped over-
night (CFS patients) or processed immediately (healthy
controls). The blood collection tubes from each individual
were consolidated into one 50 ml tube and diluted with
PBS, containing CaCl2 and MgCl2 (Sigma) at a 1:1 ratio.
15 ml of Ficoll (GE Healthcare) was added to two new 50
ml tubes, and 25 ml of the diluted blood was gently layered
on top of the Ficoll, followed by a 30 min centrifugation in
a Sorvall RT7plus rotor at 2000 rpm at room temperature
and collection of PBMCs from the interface. 10 ml of
plasma were also collected from each sample and stored at
-80°C. The collected PBMCs were diluted with PBS (2005
collection) or RPMI-1640 Medium (Sigma), supplemented
with 10% FCS (Gemini BioProducts), 100 U/ml penicillin
(Sigma), 0.1 mg/ml streptomycin (Sigma), 2 mM L-gluta-
mine (Sigma), and 1 mM sodium pyruvate (Sigma) (2010
collection) (2009-2010 collection) (complete RPMI) at a
1:1 ratio and then pelleted at 2000 rpm for 5 min. The
supernatant was aspirated, and the pellet of PBMCs was
resuspended in 20 ml of PBS (2005 collection) or complete
RPMI (2009-2010 collection). Cells were counted using a
light microscope and a hemocytometer, aliquoted to 5 ×
10
6 cells per tube, spun down and resuspended in 350 μl
of Buffer RLT Plus (Qiagen) (1% b-mercaptoethanol).
Samples were stored in this lysis buffer at -80°C.
DNA isolation from PBMCs
DNA was isolated using the procedures provided by the All-
Prep DNA/RNA Mini Kit (Qiagen). Briefly, 350 μlo fP B M C
lysate (RLT buffer, see above) (5 × 10
6 cells) were placed on
the DNA spin column, which was centrifuged at 10,000
rpm for 30 s in an Eppendorf 5417C Centrifuge. The col-
umn was then transferred to a new collection tube. 500 μl
AW1 Buffer (Qiagen) was added to the column, followed by
a 15 s spin at 10,000 rpm. The flow-through was discarded,
and the column was transferred to a new collection tube.
500 μl of AW2 Buffer (Qiagen) was added to the column,
followed by a 2 minute centrifugation at full speed. The
flow-through was discarded, and the column was transferred
to a new 1.5 ml collection tube. 100 μlo fB u f f e rE B( Q i a g e n )
was added directly to the column, followed by 1 minute
incubation at room temperature. Finally, the column was
centrifuged at 10,000 rpm for 1 min to elute DNA. DNA
concentration was determined using 1 μlo fs a m p l eo na
Thermo Scientific Nanodrop 2000 Spectrophotometer.
TaqMan qPCR assay for XMRV pol
Primers and probe, as designed by Schlaberg et al. [2],
w e r eo r d e r e df r o mA p p l i e dB i o s y s t e m s( s e eT a b l e2f o r
sequences). The reaction mix for the TaqMan qPCRs
contained 1× Gene Expression Master Mix (Applied
Biosystems), 900 nM forward and reverse primers, 250
nM probe, and 200 ng of DNA in a reaction volume of
20 μl .T h ea s s a yw a sv a l i d a t e dw i t hD N Af r o mt h e
WPI-1282 cell line containing VP62 XMRV (kindly sup-
plied by J. Mikovits, WPI). The same DNA served as
positive control in each assay, which also included a no-
template negative control. Thermocycler conditions
were 95°C for 10 minutes, followed by 60 cycles of 95°C
for 15 s and then 60°C for 1 minute, using 96-well
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Real Time PCR System by Applied Biosystems. All reac-
tions were performed in triplicate. Quality of DNA was
assessed using a TaqMan qPCR for the ribosomal 18 S
gene in the same reaction (Applied Biosystems).
Nested PCR assay for XMRV gag
Identical primers as originally described by Urisman et al.
[1] and also employed by the Mikovits group [3] were
used. The reaction mix for all PCRs consisted of 1× Hot-
Start-IT™FideliTaq™Master Mix, 200 nM forward and
reverse primers, and 200 ng of sample DNA in a 50 μl
reaction volume. The WPI-1282 lymphoblastoid cell line
was used as a positive control [3]. Thermocycler condi-
tions for the first PCR were 2 minutes at 94°C, followed by
30 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 45 s
and then finished off with 72°C for 7 minutes. Once the
first PCR was complete, 2 μl of DNA from the first PCR
was used for the second PCR. The second PCR consisted
of 1× HotStart-IT™FideliTaq™Master Mix, 200 nM forward
and reverse primers, and 200 ng of sample DNA in a 50 μl
reaction volume. Thermocycler conditions for the second
PCR were 2 minutes at 94°C, followed by 30 cycles of 94°C
for 30 s, 60°C for 30 s, and 72°C for 30 s and then finished
off with 72°C for 7 minutes. Once the second PCR was
complete, 15 μl of the samples were run on a 1.5% agarose
gel for 1 h at 100 volts. Images of gels were taken using a
VersaDoc Imaging System (Biorad). The expected frag-
ment size of the second PCR is 413 bp [1].
All positive samples from the second XMRV nested PCR
were isolated using a Qiaquick PCR Purification Kit (Qia-
gen). DNA sequencing was performed by the Tufts Uni-
versity Core Facility. Once sequenced, the traces were
monitored for double peaks, and sequences with double
peaks were discarded. Samples that had mixed sequences
were diluted, and the nested PCR was repeated. Only
clean sequences with the forward sequence matching the
reverse sequence were used for phylogenetic analysis.
TaqMan qPCR assay for mouse mitochondrial cox2
Sequences for primers and probes were kindly supplied
by Dr. Switzer, CDC (Personal Communication) (see
Table 2). Primers and Probes were ordered from
Applied Biosystems. The reaction mix contained 1×
Gene Expression Master Mix (Applied Biosystems),
900 nM forward and reverse primers, 250 nM probe,
and 200 ng of DNA in a reaction volume of 20 μl. DNA
isolated from the murine EL4 cell line, diluted in 200 ng
of human LNCaP DNA, was used as a positive control.
Thermocycler conditions were 95°C for 9 minutes, fol-
lowed by 60 cycles of 95°C for 30 s and 62°C for 30 s.
96-well plates were used on a 7300 Real Time PCR Sys-
tem by Applied Biosystems. All reactions were per-
formed in duplicate or triplicate. Quality of DNA was
assessed using a TaqMan qPCR for the ribosomal 18 S
gene in the same reaction (Applied Biosystems).
PCR assay for Mouse IAP sequences
P r i m e r sw e r ed e s i g n e db yt h eC o f f i nL a b o r a t o r y( O C
and JMC, in preparation) and ordered from Invitrogen.
The reaction mix for all PCRs consisted of 1× HotStart-
IT™FideliTaq™Master Mix, 1 μM forward and reverse
primers, and 200 ng of sample DNA in a 50 μlr e a c t i o n
volume. DNA isolated from the murine EL4 cell line
was diluted into 200 ng of human DNA (LNCaP) and
used as a positive control. Thermocycler conditions
were 94°C for 2 minutes, followed by 45 cycles of 94°C
for 30 s, 58°C for 30 s, and 72°C for 20 s and then fin-
ished off with 72°C for 7 minutes. Samples were then
run on a 1.5% agarose gel with sequence lengths varying
between 200 and 300 bp. Images of gels were taken
using a VersaDoc Imaging System (Biorad). IAP PCR
products were cloned and sequenced and yielded the
expected results (see Additional File 2; Figure S1).
Additional material
Additional File 1: Supplementary Table 1 - List of identical
sequences grouped into clusters for analysis. Each cluster contains
fragments that are identical in the corresponding 382 bp gag region.
Additional File 2: Supplemental Figure 1 - IAP sequences. IAP
sequences amplified from the indicated control human DNA samples
using the primers shown in Table II were cloned into a TOPO vector and
sequenced. Four representative sequences are shown. Each sequence
had a 100% match in the sequenced mouse genome. Adenine (A) =
Green, Cytosine (C) = Blue, Guanine (G) = Black, Thymine (T) = Red.
Table 2 Primers and probes used for TaqMan qPCRs,
primary PCRs, and nested PCRs.
Primer Sequence
XMRV4552F 5’-CGA GAG GCA GCC ATG AAG G-3’
XMRV4673R 5’-CCC AGT TCC CGT AGT CTT TTG AG-3’
XMRV4572MGB 5’-6FAM-AGT TCT AGA AAC CTC TAC ACT C-MGBNFQ-3’
GAG-O-F 5’-CGC GTC TGA TTT GTT TTG TT-3’
GAG-O-R 5’-CCG CCT CTT CTT CAT TGT TC-3’
GAG-I-F 5’-TCT CGA GAT CAT GGG ACA GA-3’
GAG-I-R 5’-AGA GGG TAA GGG CAG GGT AA-3’
MCox2-F2 5’-TTC TAC CAG CTG TAA TCC TTA-3’
MCox2-R1 5’-GTT TTA GGT CGT TTG TTG GGA T-3’
MCox2-PR1 5’-FAM-CGT AGC TTC AGT ATC ATT GGT GCC CTA TGG
T-MGBNFQ-3’
MCox2-P1 5’-FAM-TTG CTC TCC CCT CTC TAC GCA TTC TA-
MGBNFQ-3’
IAP-Forward 5’-ATA ATC TGC GCA TGA GCC AAG G-3’
IAP-Reverse 5’-AGG AAG AAC ACC ACA GAC CAG A-3’
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